Testing the UK's eyes

Article

"The Big Eye Test", a programme to provide privately-funded eye examinations to the general public, has been launched in the UK.

"The Big Eye Test", a programme to provide privately-funded eye examinations to the general public, has been launched in the UK.

The initiative was launched by optician chain Vision Express as a response to research showing that the UK general public has a low uptake of eye tests: a Government poll showed that 60% of respondents had spent nothing on eye health in the previous year, 27% had not had their eyes tested in the previous two years, 5% had not had their eyes tested for more than 10 years, and 8% of 18–24 year olds had never had an eye test.

Among the schemes to be offered under the new initiative are: digital retinal scanning, provided free of charge, for children up to the age of 16; an in-school eye-care education programme; improving optometrists’ ability to diagnose eye conditions, through a partnership with the Institute of Ophthalmology.

Recent Videos
Dr Rick Lewis discusses the FLigHT procedure and ViaLase laser at the 2024 European Society of Cataract and Refractive Surgeons (ESCRS) meeting
Christiana Dinah speaks about her ASRS presentation, Real-World Treatment Outcomes With Anti-VEGF Therapy in Patients With Retinal Vein Occlusion in the UK
Chase Ludwig, MD, shared an overview of his presentation, which covered real-impact of vitrectomy surgery on the progression of AMD at the annual ASRS meeting in Stockholm, Sweden
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.